1.56
price down icon0.64%   -0.01
after-market 시간 외 거래: 1.56
loading

Acumen Pharmaceuticals Inc (ABOS) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
3.85%
17.77
18.49 16.04 13.48 13.13
Interest Income/Expense
1.00
- - - -
Operating Income/Loss
3.85%
-17.77
-18.49 -16.04 -13.48 -13.13
Nonoperating Income/Loss
45.85%
2.901
1.989 3.082 1.868 1.828
Income/Loss From Continuing Operations Before Tax
9.84%
-14.87
-16.50 -12.96 -11.61 -11.31
Income/Loss From Continuing Operations After Tax
9.84%
-14.87
-16.50 -12.96 -11.61 -11.31
Net Income/Loss
9.84%
-14.87
-16.50 -12.96 -11.61 -11.31
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,808%
59.81
3.1344 54.23 41.03 41.03
Diluted Average Shares
1,808%
59.81
3.1344 54.23 41.03 41.03
Basic Earnings Per Share
13.79%
-0.25
-0.29 -0.24 -0.28 -0.28
Diluted Earnings Per Share
13.79%
-0.25
-0.29 -0.24 -0.28 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
자본화:     |  볼륨(24시간):